NSB 12.8% 3.4¢ neuroscientific biopharmaceuticals ltd

Ann: Company Presentation, page-4

  1. 604 Posts.
    lightbulb Created with Sketch. 60
    neurology 1H 2022: could be any date up to 30th June to start the clinical trial
    Ophthalmology 2H 2022: could be any date till 31st Dec to start the clinical trial

    it would be nice if clinical trials get started sooner so the SP can go up sooner. but just got to be patient. I wouldn't be surprised if neurology got pushed into 2H 2022 and Ophthal into 1H 2023

    I feel its a good buy and long term hold (min 1 year)

 
watchlist Created with Sketch. Add NSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.